4th Laupheim Biotech Days
Programm
| 14:00 | Tour of Rentschler’s facility Rentschler Biotechnologie GmbH Laupheim, Germany |
|---|---|
| 17:00 | Reception & exhibition Kulturhaus Schloss Großlaupheim Laupheim, Germany |
| 18:00 | Welcome Rentschler Biotechnologie GmbH Laupheim, Germany Genetic Engineering in Cell Culture Engineering: A forward-looking review Hansjörg Hauser |
| 19:30 | Dinner at the historical castle Kulturhaus Schloss Großlaupheim Laupheim, Germany |
| 09:00 | Welcome Stefan Schmidt |
|---|---|
| 09:10 | Therapeutic fusion proteins: Current trends and challenges Stefan Schmidt |
| 09:30 | PASylation: design of biologics with extended plasma half-life by genetic fusion with structurally disordered Pro/Ala-rich sequences as an alternative to chemical PEGylation Arne Skerra |
|---|---|
| 10:00 | Recombinant albumin fusion proteins and half-life extension Hubert Metzner |
| 10:30 | Coffee break |
| 11:00 | Hexavalent fusion proteins for cancer treatment and immune modulation: TRAIL, CD40L and beyond Oliver Hill |
|---|---|
| 11:30 | TNF superfamily (TNFSF) ligand fusion proteins with enhanced receptor stimulatory activity Harald Wajant |
| 12:00 | Antibody-ribonuclease fusion proteins (ImmunoRNases) for cancer therapy Michaela Arndt |
| 12:30 | Lunch break and exhibition |
| 13:30 | Armed antibodies (from the bench to the clinic), with a special focus on antibody-cytokine fusion proteins Dario Neri |
|---|---|
| 14:00 | Fynomabs Wibke Lembke |
| 14:30 | Boosting natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies and bispecific immunoligands Matthias Peipp |
| 15:00 | Coffee break |
| 15:30 | Development of TandAbs for hematological and solid tumors Erich Rajkovic |
|---|---|
| 16:00 | Nonclinical assessment of bispecific T-cell engaging antibody constructs (BiTE ®) and their transition into the clinic Benno Rattel |
| 16:30 | Old target - new mode of action: how to create truly potent anti-ErbB2 agents Martin Schwill |
| 17:00 | Final remarks and farewell “Get-Together” |
